Development of a genetically encoded and potent PDE6D inhibitor
Authors:
- Atanasio Gómez-MulasAGAtanasio Gómez-Mulas
- Elisabeth Schaffner-ReckingerESElisabeth Schaffner-Reckinger
- Hanne PeetersHPHanne Peeters
- Rohan ChippalkattiRCRohan Chippalkatti
- Arnela DautbasicADArnela Dautbasic
- Matthew James SmithMSMatthew James Smith
- Shehab IsmailSIShehab Ismail
- Daniel Kwaku AbankwaDADaniel Kwaku Abankwa
Preprint
Abstract
PDE6D is a trafficking chaperone of prenylated proteins, such as small GTPases. Several small molecule inhibitors have been developed against it, given that the oncogene K-Ras is one of the cargo proteins. Inhibitor development suffered from the fact that inhibitors against the hydrophobic pocket of PDE6D were typically poorly water-soluble. Here we describe the development of genetically encoded inhibitors that are inspired by high-affinity natural cargo of PDE6D. Our most potent inhibitor, SNAP-STI, encodes merely a farnesylated tetra-peptide, which efficiently blocks PDE6D binding of farnesylated cargo. Direct comparison with small molecule PDE6D inhibitors suggests its higher potency. We show that inhibition of K-Ras membrane anchorage and K-RasG12C-dependent MAPK-signaling by SNAP-STI is weak, consistent with what is observed after PDE6D knockdown. Our data therefore further support that PDE6D is not a suitable surrogate target for efficient inhibition of K-Ras membrane anchorage and MAPK-activity. Nonetheless, by exploiting contacts at the pocket entry, we established a generalizable strategy to design high-affinity PDE6D inhibitors, providing powerful tools for PDE6D biology and target validation.Keywords
All Related Versions
- Published version: ChemBioChem, 26 (24), e202500739.
Funding Information
- Luxembourg National Research Fund
- Fonds Wetenschappelijk Onderzoek (G042824N)
This publication has 29 references indexed in Scilit:
- Protocol to measure and analyze protein interactions in mammalian cells using bioluminescence resonance energy transferSTAR Protocols, 2024
- An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell GrowthJournal of Medicinal Chemistry, 2024
- Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS SignalingJournal of Medicinal Chemistry, 2022
- Drug targeting opportunities en route to Ras nanoclusters2022
- FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage2021
- Lipidated Stapled Peptides Targeting the Acyl Binding Protein UNC119ChemBioChem, 2019
- RAS Proteins and Their Regulators in Human DiseaseCell, 2017
- A HomozygousPDE6DMutation in Joubert Syndrome Impairs Targeting of Farnesylated INPP5E Protein to the Primary CiliumHuman Mutation, 2013
- Synthesis of the Rheb and K‐Ras4B GTPasesAngewandte Chemie International Edition, 2010
- The Vertebrate Primary Cilium in Development, Homeostasis, and DiseaseCell, 2009